“Another analysis of recurrence among ER+ patients found that use of tamoxifen therapy significantly improved patient outcomes in a population considered to be at minimal risk prior to this trial. However, even with adjuvant therapy, more than 20% of node-negative patients had their disease recur within 15 years after diagnosis. 11”
Ah, not that encouraging, is it?
some other links, mostly for my reference